celecoxib has been researched along with Crohn Disease in 2 studies
Crohn Disease: A chronic transmural inflammation that may involve any part of the DIGESTIVE TRACT from MOUTH to ANUS, mostly found in the ILEUM, the CECUM, and the COLON. In Crohn disease, the inflammation, extending through the intestinal wall from the MUCOSA to the serosa, is characteristically asymmetric and segmental. Epithelioid GRANULOMAS may be seen in some patients.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with Crohn's disease, ulcerative colitis, or pouchitis who used celecoxib or rofecoxib were identified from computerized prescription records." | 3.71 | Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease. ( Loftus, EV; Mahadevan, U; Sandborn, WJ; Tremaine, WJ, 2002) |
| " While these drugs effectively reduce musculoskeletal pain and stiffness, long-term use is limited by gastrointestinal (GI) adverse effects (AEs) and disease exacerbation." | 2.50 | Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease. ( Hu, RW; Li, HY; Li, JS; Miao, XP; Ouyang, Q; Zhang, Y, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miao, XP | 1 |
| Li, JS | 1 |
| Ouyang, Q | 1 |
| Hu, RW | 1 |
| Zhang, Y | 1 |
| Li, HY | 1 |
| Mahadevan, U | 1 |
| Loftus, EV | 1 |
| Tremaine, WJ | 1 |
| Sandborn, WJ | 1 |
1 review available for celecoxib and Crohn Disease
| Article | Year |
|---|---|
Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Colitis, Ulcerative; Crohn Disease; Cyclooxygena | 2014 |
1 other study available for celecoxib and Crohn Disease
| Article | Year |
|---|---|
Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease.
Topics: Adult; Aged; Celecoxib; Colitis, Ulcerative; Crohn Disease; Cyclooxygenase 2; Cyclooxygenase 2 Inhib | 2002 |